[ad_1] Following the reopening of its offer on TiGenix, Takeda holds 96.08% of the shares of biotech. A takeover bid begins on Friday after which the TiGenix share will be removed from …
Read More »[ad_1] Following the reopening of its offer on TiGenix, Takeda holds 96.08% of the shares of biotech. A takeover bid begins on Friday after which the TiGenix share will be removed from …
Read More »